AI Article Synopsis
- The study focused on minimally symptomatic Obstructive Sleep Apnea (OSA) patients and examined whether CPAP therapy could enhance vascular function.
- Results showed that while CPAP did not significantly affect arterial stiffness, it did significantly improve endothelial function and reduce daytime sleepiness.
- The findings suggest that minimally symptomatic OSA could pose a cardiovascular risk, highlighting the potential benefits of CPAP in managing these patients.
Article Abstract
Background: Minimally symptomatic OSA is a highly prevalent disorder, and the effects of CPAP on vascular function in these patients are unknown. This trial aimed to investigate whether CPAP improves vascular function in minimally symptomatic OSA.
Methods: In two centers taking part in the MOSAIC (Multicentre Obstructive Sleep Apnoea Interventional Cardiovascular) trial, 253 patients with minimally symptomatic OSA were randomized to 6 months of CPAP or standard care. Two hundred eight patients attended their follow-up visit within the predefined time window and had complete measurements of arterial stiffness (augmentation index [AIx]), and 64 patients had endothelial function measurements by brachial artery flow-mediated dilatation (FMD). Multivariable analyses adjusting for baseline measurements and minimization factors were performed to assess the effect of CPAP treatment on FMD (% dilatation) and AIx (% augmentation) compared with standard care.
Results: The mean ± SD baseline oxygen desaturation index and Epworth Sleepiness Score (ESS) of the 208 patients (age 58 ± 7.3 years, 31 women) were 13.7 ± 12.8 events/h and 8.3 ± 4.2, respectively. There was no CPAP treatment effect on arterial stiffness (AIx, -1.4%; 95% CI, -3.6 to +0.9%; P = .23), but CPAP improved endothelial function (FMD, +2.1%; 95% CI, +1.0 to +3.2%; P < .0001). CPAP reduced daytime sleepiness (ESS, -2.2; 95% CI, -3.0 to -1.5; P < .0001) compared with standard care. There was a larger improvement in FMD in patients using CPAP for > 4 h/night than those who used it less (P = .013).
Conclusions: CPAP improves endothelial function, but not arterial stiffness, in minimally symptomatic OSA. Thus, minimally symptomatic OSA may be a cardiovascular risk factor.
Trial Registry: ISRCTN Register; No.: ISRCTN 34164388; URL: http://isrctn.org.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1378/chest.13-0179 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Letter to the Editor Regarding "Failure Rates of Conservative Management of Minimally Symptomatic Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis".
World Neurosurg
December 2024
Department of Neurosurgery, The Jinyang Hospital Affiliated to Guizhou Medical University, Guiyang, China. Electronic address:
A Retrospective Study of Outcomes in a Rural Pediatric Population Treated for Venous Insufficiency.
J Pediatr Surg
December 2024
Valley Vein Health Center, 840 Delbon Ave, Turlock, CA 95382, USA; University of Central Florida, College of Medicine, 6850 Lake Nona Blvd, Orlando, FL 32827, USA.
Background: Endovascular radiofrequency ablation (RFA) and Endovascular Laser Ablation (EVLA) are minimally invasive methods to safely treat symptomatic varicose veins in pediatric patients. This research aimed to review the management of pediatric patients with venous insufficiency, evaluate the outcome, and determine the efficacy, convenience, and safety of ablation procedures in an outpatient setting.
Methods: A retrospective chart review of all patients seen at six locations from 2013 to 2024 was completed.
Cyanoacrylate Glue Ablation for Symptomatic Reflux in a Duplicated Femoral Vein: A Case Report.
Vasc Specialist Int
December 2024
Jeju Soo Cardiovascular Clinic (JSCVC), Jeju, Korea.
The literature on minimally invasive techniques specifically targeting reflux in symptomatic femoral vein duplication (FVD) is limited. We present a rare case of symptomatic reflux in FVD, successfully treated with cyanoacrylate glue ablation under ultrasonographic guidance. Our findings suggest that the unique anatomy of FVD can be effectively addressed through percutaneous endovenous glue ablation, providing a technically safe and feasible alternative without open surgery.
View Article and Find Full Text PDFTemporal trends and procedural safety of mitral valve transcatheter edge to edge repair in patients with previous CABG.
Future Cardiol
December 2024
Department of Cardiology, Sand Constellation Heart Institute, Rochester Regional Health, Rochester, NY, USA.
Introduction: Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER) is a minimally invasive procedure for patients with symptomatic mitral regurgitation. Its outcomes in patients with a history of coronary artery bypass grafting (CABG) remain unclear.
Methodology: We analyzed data from the Nationwide Inpatient Sample, using ICD-10-CM codes for M-TEER and CABG.
Real-Time Changes in the Comfort of a Toric, Monthly, Soft Contact Lens Over a Long Day of Wear.
Clin Optom (Auckl)
December 2024
Eminent Ophthalmic Services, LLC, Milledgeville, GA, USA.
Purpose: The purpose of this work was to determine the comfort performance of a toric, monthly, silicon hydrogel CL (lehfilcon A; TOTAL30 for Astigmatism) over a long day of wear.
Methods: This was a 1-month, 3-visit, prospective, single-arm study. Adult, 18- to 45-year-old CL wearers with good vision who were minimally symptomatic (CLDEQ-8 scores ≤12) were enrolled.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!